News

1. Stevanato Group Appoints Riccardo Butta As President, Americas 2/2/2022

   The appointment of a dedicated executive to lead the Company’s long-term strategy in the Americas is indicative of the growing regional demand trends and the Company’s commitment to broaden its footprint, accelerate its market penetration and improve proximity to its customers in this important region.

2. Esteve Increases Its Production Capacity In Spain 2/1/2022

   As part of our strategy to strengthen Esteve’s CDMO business to continue supporting our customers with the best service on contract manufacturing and development of API and pharmaceutical intermediates, Esteve has acquired another cGMP manufacturing site to widen our manufacturing platform in three continents.

3. IDT Biologika Is Increasing Its Production Capacity Of Vaccines, Saxony-Anhalt's Prime Minister Reiner Haseloff Visited The New Facilities 1/24/2022

   IDT Biologika, a leading, German-based contract development and manufacturing organization (CDMO) specialized in vaccines, gene and immune therapy as well as oncolytic viruses, is increasing its production capacity.

4. PCI Invests In Second Commercial Scale Contained Manufacturing Facility 1/19/2022

   PCI Tredegar is excited to announce significant investment in additional capacity and capabilities, adding to the already world-recognized Center of Excellence for the manufacturing of highly potent products.

5. Adare Pharma Solutions Announces Appointment Of Tom Sellig As Chief Executive Officer 1/6/2022

   Sellig, a 30-year veteran of the pharmaceutical and life sciences industries, will lead the organization in supporting pharmaceutical companies in the development and manufacturing of transformative medicines that improve patient health and outcomes.

6. PCI Adds Highly Complementary Services With The Acquisition Of LSNE 12/16/2021

   This acquisition is a key step for PCI, as LSNE will expand our breadth of services as a global CDMO, building on its expertise in specialty manufacturing, clinical trial supply and pharmaceutical packaging.

7. Valneva And IDT Biologika Announce Collaboration For Production Of Inactivated COVID-19 Vaccine VLA2001 12/15/2021

   Under the collaboration, IDT Biologika will produce VLA2001’s drug substance at its Biosafety Level 3 facilities in Dessau-Roßlau, Germany, in addition to Valneva’s manufacturing site in Livingston, Scotland.

8. Fareva And ApiJect Sign A Licensing Agreement To Create A France-Based 500M Unit Annual Capacity For Single-Dose Prefilled Vaccine Injections 12/9/2021

   Fareva and ApiJect Systems, Corp. announced a 10-year licensing agreement to install three Blow-Fill-Seal production lines that when operational will be able to fill-finish more than 500 million doses per year of vaccines and other large molecule injectable drugs using ApiJect’s innovative prefilled injector technology.

9. Roberto Almodóvar Febles Joins Pii As Head Of Aseptic Operations 8/31/2021

   Roberto Almodóvar Febles will oversee and manage day-to-day aseptic manufacturing and work closely with Sam Chia, the Head of Aseptic Manufacturing Science and Technology (MS&T) and the Operations Leadership Team (OLT) members.

10. Sharp Purchases New Land As Part Of $17 Million Capacity Expansion 6/10/2021

    The new 4-acre plot is directly adjacent to Sharp’s two existing commercial pharmaceutical packaging buildings, which collectively form the organization’s Blistering Centre of Excellence and is the latest addition to an ongoing capacity expansion project at the Conshohocken campus.